Dova Pharmaceuticals Inc (DOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,427 | -13,770 | -29,955 | -20,654 | -10,931 |
| Depreciation Amortization | 197 | 3 | N/A | N/A | N/A |
| Accounts receivable | -3,409 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 279 | -832 | 1,106 | 428 | 14 |
| Other Working Capital | 2,536 | -790 | 1,942 | 972 | 731 |
| Other Operating Activity | 10,172 | 3,648 | 16,008 | 12,996 | 7,175 |
| Operating Cash Flow | $-23,652 | $-11,741 | $-10,899 | $-6,258 | $-3,011 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -239 | -129 | -62 | -35 | -34 |
| Purchase Sale Intangibles | N/A | N/A | -1,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,000 | 0 | 0 |
| Investing Cash Flow | $-239 | $-129 | $-1,062 | $-35 | $-34 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 80,125 | 80,045 | 86,413 | 86,313 | N/A |
| Other Financing Activity | -36,385 | -36,124 | -8,315 | -8,315 | -902 |
| Financing Cash Flow | $63,740 | $43,921 | $78,098 | $77,998 | $-902 |
| Beginning Cash Position | 94,846 | 94,846 | 28,709 | 28,709 | 28,709 |
| End Cash Position | 134,695 | 126,897 | 94,846 | 100,414 | 24,762 |
| Net Cash Flow | $39,849 | $32,051 | $66,137 | $71,705 | $-3,947 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,652 | -11,741 | -10,899 | -6,258 | -3,011 |
| Capital Expenditure | -239 | -129 | -62 | -35 | -34 |
| Free Cash Flow | -23,891 | -11,870 | -10,961 | -6,293 | -3,045 |